FEATURED SPEAKERS FOR 2018
Dr. Sunit Maity is trained as Developmental/Cardiovascular Biologists in Leuven, Belgium where he received his PhD. He worked in industry (Mermaid Pharmaceuticals, Hamburg Germany) for three years where he was involved in target identification using model system. At Max Planck Institute he was involved in the CNS development related project. In 2007, at Avesthagen he headed the biosimilar group. He was responsible for development of biologics including recombinant protein and monoclonal antibodies using mammalian expression system. He is associated with Zumutor Biologics since its inception and currently works as Director of Product Development team. Zumutor is heavily invested to develop novel monoclonal antibody drugs in the Immune-Oncology segment that is driven by patient requirement for more effective drugs with reduced side effects.